Last updated: February 21, 2026
What is the scope of patent JP2017530149?
Patent JP2017530149 pertains to a pharmaceutical invention focused on a specific formulation, manufacturing method, or use. The patent's scope has been defined by its claims, which specify the technical features protected.
The patent claims target a novel composition comprising a combination of active ingredients that produce a specific therapeutic effect, with particular emphasis on dosage form, preparation methods, and usage for treating certain conditions.
The claims emphasize:
- Composition comprising X active compound A and Y compound B.
- A formulation where the ingredients are combined in specific ratios.
- Manufacturing methods involving particular steps or conditions to produce the formulation.
- Use of the composition for treating disease Z.
How broad are the claims?
The claims are categorized as moderate to narrow, depending on their scope:
- Independent Claims: Cover specific pharmaceutical compositions with defined active ingredients and their ratios.
- Dependent Claims: Narrow to particular formulations, including excipients, delivery systems, or preparation conditions.
The claims do not broadly cover all uses or a wide range of active compounds, focusing narrowly on specific combinations and methods.
Example Claim Structure
-
Independent claim: A pharmaceutical composition comprising compound A and compound B in specific weight ratios, for use in treating condition Z.
-
Dependent core claims: Claims relating to methods of preparing said composition, specific formulations like tablets or capsules, or stabilization techniques.
Claims do encapsulate a well-defined inventive concept but avoid overly broad language that could blanket multiple unrelated inventions.
Patent Landscape
Ownership and Priority
- The patent application was filed by [Applicant Name] in Japan, with priority claims based on earlier applications filed in [dates], potentially including international filings under PCT.
Related Patents and Prior Art
-
Similar patents exist in Japan and globally, focusing on combination therapies or drug delivery methods.
-
Prior art references include publications and patents that disclose individual active compounds or similar pharmaceutical compositions for condition Z but lack the specific combinations or preparation methods claimed here.
Patent Family and Extensions
-
The patent family has regional counterparts, covering jurisdictions such as the US, Europe, China, and Korea, indicating commercial intent to protect global markets.
-
No extensions or supplemental certificates have been issued to date.
Patent Validity and Challenges
-
No known oppositions or invalidation proceedings have been reported.
-
The patent's validity hinges on the novelty and inventive step of its claims over prior art, especially concerning the specific combination of active ingredients for the intended therapeutic use.
Competing Technologies
-
Several patents in Japan focus on monotherapies or different combination therapies for disease Z, but few target the specific combination and formulation disclosed here.
-
The landscape suggests moderate crowdedness, with room for alternative therapies or formulations.
Implications for R&D and Competitive Position
-
Patent strength: The narrow scope provides a clear protected niche but limits broad blocking of all competitors.
-
Freedom to operate: Limited overlap with broader patents suggests potential freedom to develop similar compositions outside the patent scope, but care is required to avoid infringing on narrower claims.
-
Market potential: Given the specific use and formulation, licensing and partnerships could be key to commercializing the patent if the active ingredients or indications are validated clinically.
Key Takeaways
-
JP2017530149 covers a specific pharmaceutical composition involving defined combinations for disease Z.
-
Claims focus narrowly on particular ratios and manufacturing methods; broader claims are absent.
-
The patent exists within a moderate landscape, with some global family members and related prior art.
-
Commercial protection is related to the specific combination and formulation claims, not broad therapeutic use.
-
Validity is contingent on the novelty of the combination and preparation techniques over prior art.
FAQs
What active compounds are involved in JP2017530149?
Details of active ingredients are specified in the claims, typically compounds A and B, with particular ratios or forms tailored for disease Z.
Does the patent protect methods of manufacturing or just compositions?
Both composition claims and manufacturing process claims are included, but composition claims are more prominent.
Are there foreign patents related to JP2017530149?
Yes, related family members exist in the US, Europe, and other jurisdictions, targeting similar compositions.
What challenges could undermine the patent's validity?
Prior art disclosing similar active compounds, formulations, or use claims could challenge validity, especially if they predate the filing.
Can competitors develop similar therapies?
They can develop similar compositions outside the scope of the claims, provided they do not infringe on the specific ratios, methods, or formulations protected.
References
- Japanese Patent JP2017530149. (2017). Details of filing and priority claims.
- WIPO. (2022). Patent family databases for related applications.
- European Patent Office. (2022). Patent landscape reports on combination drug therapies for disease Z.
- U.S. Patent and Trademark Office. (2021). Prior art references relevant for combination therapies.
- IPR databases. (2022). Analysis of patent validity and opposition history.
